 Connection
Hitoshi Irabu to Biomarkers
This is a "connection" page, showing publications Hitoshi Irabu has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.064 |
|
|
|
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy. J Immunol Res. 2020; 2020:4284379.
Score: 0.283
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Tasaki Y, Ohta K, Yachie A, Wada T. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis. Pediatr Res. 2021 02; 89(3):667-672.
Score: 0.283
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy. Pediatr Res. 2020 12; 88(6):934-939.
Score: 0.280
-
Usami M, Shimizu M, Mizuta M, Inoue N, Irabu H, Sakumura N, Nakagishi Y, Yachie A. Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus. Clin Immunol. 2019 11; 208:108255.
Score: 0.067
-
Kaneko S, Shimbo A, Irabu H, Mizuta M, Nakagishi Y, Iwata N, Yokoyama K, Yasumura J, Akamine K, Ueno K, Fujita S, Watanabe K, Watanabe S, Nishikawa H, Fujimura J, Mori M, Shimizu M. Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis. Cytokine. 2024 10; 182:156719.
Score: 0.024
-
Kaneko S, Shimbo A, Irabu H, Hatano M, Takasawa K, Kamiya T, Akamine K, Tanaka T, Minato T, Ono M, Yokoyama K, Arisaka A, Yasumi T, Ueno K, Fujita S, Tanaka Y, Hayashi D, Nishikawa H, Fujita Y, Yuza Y, Mori M, Morio T, Shimizu M. Pathogenic role and diagnostic utility of interferon-a in histiocytic necrotizing lymphadenitis. Clin Immunol. 2024 Sep; 266:110324.
Score: 0.024
-
Kaneko S, Shimizu M, Miyaoka F, Shimbo A, Irabu H, Mizuta M, Nakagishi Y, Iwata N, Fujimura J, Mori M, Morio T. The dynamics of laboratory markers reflecting cytokine overproduction in macrophage activation syndrome complicated with systemic juvenile idiopathic arthritis. Clin Immunol. 2023 03; 248:109270.
Score: 0.021
-
Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, Wada T, Yachie A. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Rheumatology (Oxford). 2021 01 05; 60(1):231-238.
Score: 0.018
-
Sakumura N, Irabu H, Inoue N, Mizuta M, Shimizu M. Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab. Rheumatology (Oxford). 2020 01 01; 59(1):252-254.
Score: 0.017
-
Takakura M, Shimizu M, Irabu H, Sakumura N, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Clin Immunol. 2019 11; 208:108252.
Score: 0.017
-
Jinkawa A, Shimizu M, Nishida K, Kaneko S, Usami M, Sakumura N, Irabu H, Takakuwa M, Inoue N, Mizuta M, Ikawa Y, Fujita S, Yachie A. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease. Cytokine. 2019 07; 119:52-56.
Score: 0.016
-
Shimizu M, Inoue N, Kuroda M, Irabu H, Takakura M, Kaneda H, Sugimoto N, Ohta K, Yachie A. Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Clin Exp Nephrol. 2017 Dec; 21(6):1083-1087.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|